SCHOLAR ROCK HOLDING CORPORATION Repayments of Debt
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Repayments of Debt of $365.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2021-03-09
- SCHOLAR ROCK HOLDING CORPORATION repayments of debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION repayments of debt for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION repayments of debt for the quarter ending 2019-06-30 was $198.00K, a 19.28% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION repayments of debt for the quarter ending 2019-03-31 was $167.00K, a 0.00% change year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION repayments of debt for fiscal 2019 was $365.00K, a 45.28% decline from fiscal 2018.
- SCHOLAR ROCK HOLDING CORPORATION repayments of debt for fiscal 2018 was $667.00K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-09 | $198.00K derived: sum of 3 quarters · filed 2021-03-09 | $365.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $198.00K derived: sum of 2 quarters · filed 2020-11-09 | $365.00K 10-Q · filed 2020-11-09 | $532.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $365.00K 10-Q · filed 2020-08-07 | $532.00K derived: sum of 3 quarters · filed 2020-08-07 | $699.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $167.00K 10-Q · filed 2020-05-07 | $334.00K derived: sum of 2 quarters · filed 2020-05-07 | $501.00K derived: sum of 3 quarters · filed 2020-05-07 | $667.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $334.00K derived: sum of 2 quarters · filed 2020-03-12 | $500.00K derived: sum of 3 quarters · filed 2020-03-12 | $667.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $333.00K derived: sum of 2 quarters · filed 2019-11-12 | $500.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $333.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $167.00K 10-Q · filed 2019-05-15 | |||
| 2017-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $500.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $333.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |